Browse Morrison, Trista

1-1 out of 1 article(s)

Title	Type	Date	Words
End of the road for La Jolla? As a futility analysis derails BioMarin and LJP's Phase III Riquent trial, Trista Morrison, Bioworld.com, wonders if this is the end of Riquent and asks what the future holds for La Jolla Pharmaceuticals.		May 1, 2009	821

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	before 1995 1995-1999 2000-2004 2005-2009 2010-	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z